等待开盘 04-01 09:30:00 美东时间
+0.070
+1.28%
Inventiva says JPMorgan holds 5.99% beneficial stake Inventiva disclosed J.P. Morgan Chase dropped below 5% voting rights on March 26, 2026, holding 10.5 million shares. Stake equaled 5.05% of share capital, representing 4.72% of voting rights at that time. J.P. Morgan Chase moved back above 5% voti
今天 08:09
周二股市上涨,油价小幅走高,《华尔街曰报》报道称,美国总统特朗普已释放信号,表示他愿意结束美国针对伊朗的军事行动。 截至发稿,道指期货涨1.01%,标普...
03-31 20:30
Inventiva S.A press release (IVA): FY GAAP EPS of -Є1.90. Revenue of Є4.5M (-51.0% Y/Y). More on Inventiva S.A Inventiva S.A. (IVA) Presents at Barclays 28th Annual Global Healthcare Conference Transc...
03-31 04:19
Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(1.66) by 28.92 percent. This is a 35.74 percent increase over losses of $(3.33) per share from the
03-31 04:15
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-market gainers include ONCO, VSA, GMEX, IZM, GVH, BATL, U, SGML, & GLND. Losers are SLND, DTCX, TOP, SVRN, & GAUZ.
03-27 18:00
J.P. Morgan Chase crosses 5% stake in Inventiva with 5.78% of capital JPMorgan Chase reported crossing above the 5% thresholds in Inventiva’s share capital and voting rights through controlled entities. It held 12,001,176 shares, representing 5.78% of the capital and 5.4% of voting rights. Disclaime
03-23 18:12
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
Truist Securities analyst Srikripa Devarakonda initiates coverage on Inventiva (NASDAQ:IVA) with a Buy rating and announces Price Target of $13.
03-19 18:12
Inventiva CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat Inventiva SA will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, which takes place on February 11-12, 2026, at the Lotte New York Palace in New York City. CEO Andrew Obenshain is scheduled for a fire
02-05 05:00